Bibliography to Chapter 3

Mick Mulders

  1. World Health Organization. Guidance on regulations for the Transport of Infectious Substances 2017-2018. 2017.
  2. Stambos V et al. Evaluation of the World Health Organization global measles and rubella quality assurance program, 2001-2008. Journal of Infectious Diseases, 2011, Jul;204 Suppl 1:S499-505.
  3. World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. 2010.
  4. Helfand RF et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. Journal of Infectious Diseases, 1997, 175(1): p. 195-9.
  5. Bellini WJ, Icenogle JP. Measles and rubella viruses, in Manual of Clinical Microbiology, Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, editors. 9th edition, 2007, ASM Press.
  6. Centers for Disease Control and Prevention. Recommendations from an ad hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance. MMWR Morbidity and Mortality Weekly Report, 2008, 57(24): 657-660.
  7. WHO. Measles and rubella laboratory network: 2007 meeting on use of alternative sampling techniques for surveillance. Weekly Epidemiological Record, 2008, 83(25): 229-232.
  8. Adam O et al. 2014. Identification of congenital rubella syndrome in Sudan. BMC Infectious Diseases, 2014, 14:305
  9. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(No. RR-12)